FORM 20-F (Mark One) ☐REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☐SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of event requiring this shell company report Table of Contents UNITE ...

Baird Medical's presence at the AAES 2025 meeting highlights the growing significance of its MWA technology in the evolving landscape of minimally invasive treatment options for endocrine conditions, particularly thyroid nodules. The participation provides an excellent opportunity for the Company to engage with key opinion leaders in endocrine surgery, share clinical updates on its MWA systems, and contribute to discussions on innovative patient care strategies. The AAES Annual Meeting is widely regarded as ...

Core Insights - Baird Medical is advancing minimally invasive thyroid therapies through specialized training programs and collaboration with medical leaders [3][4] - Dr. Shahzad Ahmad, a prominent endocrinologist, completed training in microwave ablation (MWA) techniques, enhancing his clinical skills [2][4] - The company aims to improve patient outcomes with innovative surgical technologies and has established a strong presence in the U.S. and China [4] Company Overview - Baird Medical specializes in minimally invasive diagnostics and treatments, focusing on surgical robotic systems and advanced surgical instruments [4] - The company is FDA 510(k)-certified and its solutions are utilized in over 30 prestigious hospitals and clinics across the U.S. [4] - Baird Medical is a market leader in China for thyroid microwave ablation devices and is expanding its commercial presence in over 20 countries [4]

Dr. Tse observed multiple thyroid nodule ablation procedures at Sun Yat-sen University Cancer Center, gaining valuable insights into the precision and clinical efficacy of Baird Medical's MWA system. In addition to the procedural observations, Dr. Tse participated in academic discussions with Dr. Michael Mingzhao Xing, Professor Emeritus at the Johns Hopkins University School of Medicine. Together, they explored the latest advancements and clinical outcomes in thyroid nodule management. Dr. Tse's visit rein ...

In preparation for market entry, Baird Medical has initiated partnerships with leading healthcare institutions across these regions to establish robust distribution networks and conduct comprehensive training programs on microwave ablation (MWA) procedures. These initiatives are strategically implemented to ensure the seamless introduction of the Company's advanced medical solutions, enabling immediate patient access upon receipt of regulatory approvals. Microwave ablation is a minimally invasive procedure ...

NEW YORK, March 17, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company") has been honored with the "Most Valuable Investment Award" at the 10th China Medical Industry Innovation Competition with its revolutionary in-development product, the "AI Tumor Ablation Surgical Robot." This prestigious recognition marks a significant milestone in the advancement of AI and robotics integration that Baird Medical is developing in the medical field. AI & Robotics: ...

"This regulatory approval marks a significant step in our global strategic expansion and underscores our commitment to improving patient care with cutting-edge, minimally invasive technologies," said Haimei Wu, Chairwoman of Baird Medical.  "We look forward to collaborating with Indonesian healthcare providers and supporting them with innovative solutions that enhance precision, safety, and patient outcomes. Microwave ablation is a highly effective, minimally invasive procedure that uses targeted microwave ...

As a premier gathering for experts in interventional endocrinology, NASOIE serves as a platform for advancing minimally invasive treatments for thyroid and parathyroid disorders. The event convenes top-tier clinicians and researchers to explore the latest breakthroughs in treating thyroid nodules and cancer recurrences. Baird Medical's presence at NASOIE 2025 drew strong engagement, with numerous physicians visiting the booth to explore the latest advancements in MWA technology. Attendees participated in ha ...

The delegation included Dr. MD Mofazzal Sharif, Dr. Mohammad Rezaul Haque, Dr. Alamgir A.B.M., and Dr. Mohammad Jannatul Ferdous Rubel, who participated in a comprehensive training program designed to enhance their expertise in MWA techniques. The program's first day featured in-depth theoretical discussions and hands-on demonstrations at Baird Medical's state-of-the-art facility, providing participants with a deeper understanding of MWA applications in clinical practice. On the second day, the delegation c ...

Led by Dr. Jennifer Kuo, Director of the Interventional Endocrinology Program and Program Director of the Endocrine Surgery Fellowship at Columbia University's Department of Surgery, the two-day course provided in-depth instruction on MWA techniques, procedural safety, and clinical applications. The program attracted physicians from the United States and Mexico, including Dr. Hosai Todd-Hesham, an Otolaryngology specialist from Maryland ENT Associates, and Dr. Camilo González Velázquez, Associate Professor ...